NGTF.png
Nightfood Secures Distribution in Central Market With Stores in the Five Largest Cities in Texas: Houston, Dallas, Fort Worth, Austin, and San Antonio
June 30, 2020 08:00 ET | NightFood Holdings, Inc.
Tarrytown, NY, June 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nightfood, Inc. (OTCQB: NGTF), the better-for-you snack company targeting the $50 billion consumers spend on nighttime snacks, is...
Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer Center Edges Closer for Hemispherx Biopharma
May 13, 2019 12:22 ET | CEOLIVE.TV
ORLANDO, FL, May 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hemispherx Biopharma Inc., (NYSE American: HEB), an immuno-pharma company focused on the research and development of therapeutics to...
AIMLogo.jpg
Hemispherx Biopharma to Present at the 9th Annual LD Micro Main Event
November 21, 2016 08:30 ET | Hemispherx Biopharma, Inc.
PHILADELPHIA, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) ("Hemispherx" or the "Company") announced today that it will be presenting at the 9th annual LD Micro Main Event...
Hemispherx Biopharma Management Team: Reflects Company’s Aggressive Commitment to Strategies Designed to Reach Commercial Goals, Preserve Financial Capital, and Increase Stockholder Value
February 22, 2016 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 22, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the “Company” or “Hemispherx”) has announced that the Board of Directors has made several changes to its...
AIMLogo.jpg
Hemispherx Biopharma Introduces a Voluntary Stock Purchase Plan to Create Shareholder Value
February 03, 2016 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Feb. 03, 2016 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) announced today, February 3, 2016, a Voluntary Pay for Stock Plan (the “Plan”).  Hemispherx Biopharma...
AIMLogo.jpg
Hemispherx Biopharma to Present at the 17th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10, 2015
September 02, 2015 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Sept. 2, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE MKT:HEB) today announced it will be featured as a presenting company at the 17th Annual Rodman & Renshaw Global...
AIMLogo.jpg
Hemispherx Biopharma's Judgment Unanimously Affirmed Against Cato Capital
August 26, 2015 10:00 ET | AIM ImmunoTech Inc.
WILMINGTON, Del., Aug. 26, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") announced that on Friday the Third Circuit Court of Appeals upheld the...
AIMLogo.jpg
Hemispherx Biopharma Reminder Regarding Stockholder Open House at Manufacturing and Research Facility in New Jersey
August 19, 2015 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 19, 2015 (GLOBE NEWSWIRE) -- As previously announced and provided in the proxy materials, the Management and the Board of Directors of Hemispherx Biopharma (NYSE MKT:HEB) will host...
AIMLogo.jpg
Hemispherx Biopharma Extends Its Strategic Alliance With Armada Health Care for Alferon N Injection(R)
August 17, 2015 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 17, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) (the "Company" or "Hemispherx"), announced that as the Company works toward the re-launch of Alferon N, it has...
Hemispherx Biopharma Board Appoints New President
August 13, 2015 08:30 ET | AIM ImmunoTech Inc.
PHILADELPHIA, Aug. 13, 2015 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx") today announced that the Board has appointed Thomas Equels as the new...